Amplify Capital, a Toronto, Canada-based impact venture firm rebranded from the MaRS Catalyst Fund after spinning out of the MaRS Discovery District in 2019, closed its Fund II, at $30.7m.
Fund II boasts a diverse investor base, with Limited Partners Royal Bank of Canada; Fondation Lucie et André Chagnon; Fondaction; VanCity; Jona Capital; and numerous Foundations and family offices.
Led by Kathryn Wortsman, Amplify invests exclusively in early-stage startups that apply innovative technologies addressing the world’s most complex and urgent problems.
Fund II will continue to grow the firm’s mission to catalyze the democratization of global health, education, and a sustainable environment (aligned with U.N. Sustainable Development Goals #3, 4, and 13, respectively).
Targeting quantitative impact outcomes, Amplify will invest $500,000 – $1,000,000 Seed and Series A funding, plus reserve for follow-on funding. The firm seeks to lead, co-lead and participate in funding companies ready to scale in these sectors.
Launched in 2020 with a first close, Fund II has already funded seven investments and has a target portfolio of 20-22 companies. Fund II investments include Alt Tex; Ditch Labs; Pathway; Sylvatex Inc; Uvaro; and Verto Health.
FinSMEs
04/02/2022